ReviewCurrent oncology (Toronto, Ont.)2023

Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS).

Josephine Lucero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.